Open AccessTHE EVALUATION OF SAFETY AND EFFICACY OF PCSK9 INHIBITOR IN PATIENTS WITH CARDIAC ALLOGRAFT VASCULOPATHY AND HYPERCHOLESTEROLEMIA
Author(s) -
Kensuke Kuroda,
Keiichiro Iwasaki,
Seiko Nakajima,
Takuya Watanabe,
Osamu Seguchi,
Masanobu Yanase,
Satsuki Fukushima,
Tomoyuki Fujita,
Junjiro Kobayashi,
Norihide Fukushima
Publication year - 2020
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000701820.44595.67
Subject(s) - medicine , evolocumab , pcsk9 , dyslipidemia , cardiology , alirocumab , familial hypercholesterolemia , transplantation , cardiomyopathy , heart transplantation , everolimus , coronary artery disease , heart failure , cholesterol , lipoprotein , disease , ldl receptor , apolipoprotein a1